title: Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
authors: A H
authors: AH
authors: Shikani
authors: K
authors: K
authors: Kourelis
authors: M A
authors: MA
authors: Alqudah
authors: H J
authors: HJ
authors: Shikani
authors: E
authors: E
authors: Cope
authors: N
authors: N
authors: Kirk
authors: D
authors: D
authors: Bergstedt
authors: R J
authors: RJ
authors: Basaraba
authors: J G
authors: JG
authors: Leid
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068656:Mometasone Furoate; D009298:Nasal Polyps / Q000150:complications*; D009330:Nebulizers and Vaporizers; D011244:Pregnadienediols / Q000008:administration & dosage*; D012220:Rhinitis / Q000150:complications / Q000188:drug therapy*; D012852:Sinusitis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D011244:Pregnadienediols; D000068656:Mometasone Furoate